These days, professionals in healthcare have learned to accept the certain fate of pharmaceutical reps and their decreasing stranglehold on the provider targets on whom they prey to essentially hock the respective pharma company’s wares.  Now-ubiquitous state statutes require pharma companies to report financial ties to physicians and their representative healthcare organizations, creating the environment Pharma finds itself in today — a culture of advertising restriction and full physician-client disclosure of association.  

One state that was originally at the vanguard of legislating and, and in many cases, restricting the amount of gifts which providers or their organizations could obtain at the hands of pharma marketing is Minnesota. Now, a MN state senator wants to craft his version of a federal bill aimed at broadening the reach of this type of full disclosure, and the objects of his legislation are the medical device companies and the physicians to and for whom they market and commission randomized trials. | LINK

Related Posts Within Doctor Pundit:

1. Healtcare Advocacy Groups Mobilize for Nationwide Listening Tour How about holding a house party discuss healthcare policy reform,...
2. Medical Student Org Publicizes Medical Schools’ Pharma Policies In a way, the “predation” of pharma companies on medical...
3. U of M Physician’s Ties to Medical Device Company Scrutinized Conflict of interest takes on an entirely new meaning in...
4. Insurance Companies Increase Donations to Fight Breadth of Public Option in Reform Just because there’s a congressional recess this month doesn’t mean...
5. Report: Minnesota’s Pharma Disclosure Laws Fail to Provide Audit Mechanism Policy wonks, regulatory agencies, legislators, and just about any interested...